VERU-111 (ABI-231) is a potent and orally active alpha and beta tubulin inhibitor, which displays strong antiproliferative activity, with an average IC50 of 5.2 nM against panels of melanoma and prostate cancer cell lines. VERU-111 (ABI-231) suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting HPV E6 and E7, and has potential for the treatment of prostate cancer[1][2][3].
Molecular Weight:
377.39
Purity:
99.00
CAS Number:
[1332881-26-1]
Formula:
C21H19N3O4
Target:
Apoptosis,HPV,Microtubule/Tubulin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
